House Panel Maps Out Plan For Cures Oversight, Obamacare Repeal
Executive Summary
The House Energy and Commerce has released its two-year oversight plans in advance of an organizational meeting. The plan features close attention to federal implementation of the 21st Century Cures Act, the efficiency of FDA product reviews, and work to repeal and replace the Affordable Care Act.
You may also be interested in...
Industry 'Encouraged' By Trump Exec Order To Undo ACA, Device Tax
Industry cheered one of President Trump's first executive orders filed Jan. 20, calling on HHS and others in the executive branch to "waive, defer, grant exemptions" from Affordable Care Act provisions for industry imposing burdens on them, including the costs of taxes and fees on "makers of medical devices."
21st Century Cures: Device Provisions
Dozens of reforms impacting the medtech sector were signed into law Dec. 13 as part of the 21st Century Cures Act. Here's a breakdown of the provisions most important to device- and diagnostic-makers.
Senate Adopts Cures Bill By Big Margin; FDA Could Tap $20m More In 2017
The Senate approved the same 21st Century Cures bill passed by the House last week on a 94-5 tally; the bill is expected to be quickly signed by President Obama. Provisions for extra dollars for FDA in the bill means that even with a plan by Congress to adopt a continuing resolution this week freezing FDA funding until April 28, the agency can rely on an additional $20 million set aside for it in Cures in the new year.